News
High resolution nucleic acid separation technologies capture significant share in large nucleic acid electrophoresis market
Nucleic Acid Separation Life Science Dashboard™ market research report released by Percepta
Associates reveals trend towards higher resolution separation methods driven by fastest
growing nucleic acid separation sub-segments

Carlsbad, CANovember 10th, 2008 – Percepta Associates announced today the release of Series
One of its Nucleic Acid Separation Life Sciences Dashboard™ market research report. This report,
which analyzes key market indicators in specific nucleic acid separation markets, reveals that several
application segments are growing more than twice the rate of the overall market average. Faster
growth in sub-segments such as cRNA analysis, small RNA analysis, and mutation detection coincides
with increasing need for higher resolution separation technologies and is driving share capture for
companies such as Agilent (NYSE: A), Bio-Rad Laboratories (AMEX: BIO), and Applied Biosystems (NYSE:
ABI). Agarose based methods are still extensively used for other growth segments such as HLA typing.
Suppliers such as Sigma-Aldrich (NASDAQ: SIAL), and Invitrogen (NASDAQ: IVGN) lead these segments.

Nucleic acid separation techniques include: self made agarose or polyacrylamide gels, precast agarose or
polyacrylamide gels, capillary electrophoresis, or lab-on-chip microfluidic methods. Nucleic acid
separation is a time tested means of analyzing nucleic acid samples for multiple applications and is
regularly performed in most life science laboratories.

Product application segments analyzed in Series One of the new Nucleic Acid Separation Life Science
DashboardTM include:
• Analyzing amplified DNA (includes AFLP)
• Analyzing restriction digested DNA (includes RFLP)
• Analyzing cRNA or total RNA quality
• Analyzing small RNA molecules
• Analyzing synthetic DNA or RNA
• STR analysis
• HLA typing analysis
• Pulsed field gel electrophoresis (includes mapping)
• Mutation detection (includes SSCP, DGGE)

“This report covers the nucleic acid separation market in great detail, by both application segment and
product type” said Mike Klein of Percepta. “Top suppliers for each technique are segmented by
geography and by customer type. It’s clear that non agarose based methods have helped some suppliers
carve out healthy and growing market niches. Analysis of supplier market share by geography and
customer type uncovers potential opportunities for second and third tier competitors to gain share”

To view nucleic acid separation market research sample data and questionnaires visit:
http://www.perceptaassociates.com/publications/08_nucleic_acid_overview.shtml

Life Science Dashboards™ are readily accessible sources of current, segment-specific, market
research. Designed and implemented by industry veterans, each dashboard provides key life
science market indicators compiled from the survey responses of qualified decision-makers and
researchers actively using life science research products. Unlike other market research reports,
Percepta's Dashboards feature an “at-a-glance” format that provides rapid access to actionable
key market indicators in an easy to understand framework, including:

• Market size
• Market share
• Market growth and reaction throughput rates
• Customer satisfaction
• Propensity to switch
• Competitive intensity
• Perceived pricing
• Top suppliers
• Technique usage frequency
• Fastest growing techniques
• Primary and secondary downstream applications

About Percepta

Founded in 2005 in Carlsbad, California Percepta Associates serves a rapidly growing roster of bioscience clients across North America and Europe. Percepta is a specialized consultancy providing expert market research, strategic business planning, portfolio management, product and corporate branding and marketing communications services. For more information visit www.perceptaassociates.com.

CONTACT:
Percepta Associates Inc.
Mike Klein
Principal
Phone: 760 597 9236
Email: mklein@perceptaassociates.com
Site Map | Privacy Policy | © 2005-2009 Percepta Associates Inc.